US Patent Issued to Attovia Therapeutics on March 3 for "IL13 and IL31 bispecific polypeptides and uses thereof" (California Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,527, issued on March 3, was assigned to Attovia Therapeutics Inc. (San Carlos, Calif.).

"IL13 and IL31 bispecific polypeptides and uses thereof" was invented by Jin Wook Choi (Pleasanton, Calif.), Lam Nguyen (Union City, Calif.), Shyr Jiann Li (Millbrae, Calif.), Jing Zhang (San Jose, Calif.), David Bellovin (San Jose, Calif.), Ole Petter Veiby (Redwood City, Calif.), Hangjun Zhan (Foster City, Calif.) and Lequn Zhao (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are bispecific polypeptides that bind IL13 and IL31 and methods of using IL13 and IL31 bispecific polypeptides to modulate the biological activity of IL13...